title: Hyperphosphatemia in multiple myeloma.
authors.forename: Leila
authors.initials: L
authors.lastname: Cheikhrouhou Abdelmoula
authors.forename: Chiraz
authors.initials: C
authors.lastname: Amira
authors.forename: Lilia
authors.initials: L
authors.lastname: Chaabouni
authors.forename: Mohamed Montacer
authors.initials: MM
authors.lastname: Kchir
authors.forename: Rafik
authors.initials: R
authors.lastname: Zouari
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications*; D010710:Phosphates / Q000097:blood; D010760:Phosphorus Metabolism Disorders / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D010710:Phosphates